The nitric oxide donor, V-PYRRO/NO, protects against acetaminophen-induced hepatotoxicity in mice

Hepatology

Volumn 37, Issue 2, 2003, Pages 324-333

  Liu, Jie ^a,b   Li, Chengxiu ^a   Waalkes, Michael P ^a   Clark, James ^b   Myers, Page ^b   Saavedra, Joseph E ^c   Keefer, Larry K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKENE DERIVATIVE; BETA ACTIN; CASPASE 3; CASPASE 8; CYTOCHROME C; CYTOCHROME P450; ENDOTOXIN; FAS ANTIGEN; FAS LIGAND; GALACTOSAMINE; GLUTATHIONE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; NCX 701; NITRIC OXIDE; NITRIC OXIDE DONOR; PARACETAMOL; PROTEIN BAX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VINYL 1 (PYRROLIDIN 1 YL)DIAZEN 1 IUM 1,2 DIOLATE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CHROMATOPHORE; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; DOSE RESPONSE; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; FEMALE; FIRST PASS EFFECT; GENE EXPRESSION; GENETIC ANALYSIS; INTOXICATION; LIPID PEROXIDATION; LIVER CIRCULATION; LIVER CONGESTION; LIVER HOMOGENATE; LIVER INJURY; LIVER TOXICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSMOTIC PUMP; OXIDATIVE STRESS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0037308128     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50063     Document Type: Article

References (38)

1. Black M. Acetaminophen hepatotoxicity. Annu Rev Med 1984;35:577-593.
2. Cohen SD, Hoivik DJ, Khairallah EA. Acetaminophen-induced hepatotoxicity. In: Plaa GL, Hewitt WR, eds. Toxicology of the Liver. 2nd ed. Washington: Taylor & Francis, 1998;159-186.
3. Dahlin DC, Miwa GT, Lu AYH, Nelson SD. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci U S A 1984;81:1327-1331.
4. Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, Brodie BB. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther 1973;187:195-202.
5. Hinson JA, Pumford NR, Roberts DW. Mechanisms of acetaminophen toxicity: immunochemical detection of drug-protein adducts. Drug Metab Rev 1995;27:73-92.
6. Mason RP, Fischer V. Free radicals of acetaminophen: their subsequent reactions and toxicological significance. Fed Proc 1986;45:2493-2499.
7. Knight TR, Kurtz A, Bajt ML, Hinson JA, Jaeschke H. Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci 2001;62:212-220.
8. Michael SL, Mayeux PR, Bucci TJ, Warbritton AR, Irwin LK, Pumford NR, Hinson JA. Acetaminophen-induced hepatotoxicity in mice lacking inducible nitric oxide synthase activity. Nitric Oxide 2001;5:432-441.
9. Fiorucci S, Antonelli E, Mencarelli A, Palazzetti B, Alvarez-Miller L, Muscara M, del Soldato P, et al. A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway. Br J Pharmacol 2002;135:589-599.
10. Futter LE, al-Swayeh OA, Moore PK. A comparison of the effect of nitroparacetamol and paracetamol on liver injury. Br J Pharmacol 2001;132:10-12.
11. Keefer LK. Design of nitric oxide-releasing drugs. Pharm News 2000;7:2732.
12. Saavedra JE, Billiar TR, Williams DL, Kim Y-M, Watkins SC, Keefer LK. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-α-induced apoptosis and toxicity in the liver. J Med Chem 1997;40:1947-1954.
13. Stinson SF, House T, Bramhall C, Saavedra JE, Keefer LK, Nims RW. Plasma pharmacokinetics of a liver-selective nitric oxide-donating diazeniumdiolate in the male C57BL/6 mouse. Xenobiotica 2002;32:339-347.
14. Ricciardi R, Foley DP, Quarfordt SH, Saavedra JE, Keefer LK, Wheeler SM, Donohue SE, et al. V-PYRRO/NO: an hepato-selective nitric oxide donor improves porcine liver hemodynamics and function after ischemia reperfusion. Transplantation 2001;71:193-198.
15. 2-Vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against D-galactosamine/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays. J Pharmacol Exp Ther 2002;300:18-25.
16. Kim Y-M, Kim T-H, Chung H-T, Talanian RV, Yin X-M, Billiar TR. Nitric oxide prevents tumor necrosis factor α-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. HEPATOLOGY 2000;32:770-778.
17. Ou J, Carlos TM, Watkins SC, Saavedra JE, Keefer LK, Kim Y-M, Harbrecht BG, et al. Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide 1997;1:404-416.
18. Deleve LD, Wang XD. Decrease in hepatic nitric oxide production contributes to hepatic veno-occlusive disease (HVOD) [Abstract]. HEPATOLOGY 1999;30(Suppl):230.
19. Moal F, Vuillemin E, Wang JH, Veal N, Oberti F, Cales P. Chronic antifibrotic and hemodynamic effects of a new liver specific NO donor (V-PYRRO/NO) in bile-duct ligated (BDL) rats [Abstract]. HEPATOLOGY 2000;32(Suppl):94.
20. Gardner CR, Heck DE, Yang CS, Thomas PE, Zhang X-J, DeGeorge GL, Laskin JD, et al. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. HEPATOLOGY 1998;27:748-754.
21. Hinson JA, Pike SL, Pumford NR, Mayeux PR. Nitrotyrosine-protein adducts in hepatic centrilobular areas following toxic doses of acetaminophen in mice. Chem Res Toxicol 1998;11:604-607.
22. Kim PKM, Billiar TR. Give me iNOS of give me death. HEPATOLOGY 2000;34:436-437.
23. Laskin JD, Heck DE, Gardner CR, Laskin D. Prooxidant and antioxidant functions of nitric oxide in liver toxicity. Antioxid Redox Signal 2001;3:261-271.
24. Bourdi M, Masubuchi Y, Reilly TP, Amouzadeh HR, Martin JL, George JW, Shah AG, et al. Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. HEPATOLOGY 2002;35:289-298.
25. Hinson JA, Bucci TJ, Irwin LK, Michael SL, Mayeux PR. Effect of inhibitors of nitric oxide synthase on acetaminophen-induced hepatotoxicity in mice. Nitric Oxide 2002;6:160-167.
26. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969;27:502-522.
27. Walker NJ. Real-time and quantitative PCR: applications to mechanism-based toxicology. J Biochem Mol Toxicol 2001;15:121-127.
28. Walker RM, Racz WJ, McElligott TF. Acetaminophen-induced hepatotoxic congestion in mice. HEPATOLOGY 1985;5:233-240.
29. Ruepp SU, Tonge RP, Shaw J, Wallis N, Pognan F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci 2002;65:135-150.
30. Nelson SD. Mechanisms of the formation and disposition of reactive metabolites that can cause acute liver injury. Drug Metab Rev 1995;27:147-177.
31. Liu J, Liu Y, Hartley D, Klaassen CD, Shehin-Johnson SE, Lucas A, Cohen SD. Metallothionein-I/II knockout mice are sensitive to acetaminopheninduced hepatotoxicity. J Pharmacol Exp Ther 1999;289:580-586.
32. Dimmeler S, Haendeler J, Sause A, Zeiher AM. Nitric oxide inhibits APO-1/Fas-mediated cell death. Cell Growth Differ 1998;9:415-422.
33. Blazka ME, Germolec DR, Simeonova P, Bruccoleri A, Pennypacker KR, Luster MI. Acetaminophen-induced hepatotoxicity is associated with early changes in NF-κB and NF-IL6 DNA binding activity. J Inflamm 1996;47:138-150.
34. Blazka ME, Bruccoleri A, Simeonova PP, Germolec DR, Pennypacker KR, Luster MI. Acetaminophen-induced hepatotoxicity is associated with early changes in AP-1 DNA binding activity. Res Commun Mol Pathol Pharmacol 1996;92:259-273.
35. Buzard GS, Kasprzak KS. Possible roles of nitric oxide and redox cell signaling in metal-induced toxicity and carcinogenesis: a review. J Environ Pathol Toxicol Oncol 2000;19:179-199.
36. Ray SD, Mumaw VR, Raje RR, Fariss MW. Protection of acetaminopheninduced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J Pharmacol Exp Ther 1996;279:1470-1483.
37. Yagnik GP, Takahashi Y, Tsoulfas G, Reid K, Murase N, Geller DA. Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury. HEPATOLOGY 2002;36:573-581.
38. DeLeve LD, Wang X, Kaplowitz N, Shulman HM, Bart JA, van der Hoek A. Sinusoidal endothelial cells as a target for acetaminophen toxicity. Direct action versus requirement for hepatocyte activation in different mouse strains. Biochem Pharmacol 1997;53:1339-1345.